CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of CAD 104.80 billion. The enterprise value is 198.32 billion.
Market Cap | 104.80B |
Enterprise Value | 198.32B |
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Shares Outstanding | n/a |
Shares Change (YoY) | -2.15% |
Shares Change (QoQ) | -0.63% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.26B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.48, with an EV/FCF ratio of 27.48.
EV / Earnings | 20.15 |
EV / Sales | 0.40 |
EV / EBITDA | 7.48 |
EV / EBIT | 12.44 |
EV / FCF | 27.48 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 1.12.
Current Ratio | 0.86 |
Quick Ratio | 0.60 |
Debt / Equity | 1.12 |
Debt / EBITDA | 4.36 |
Debt / FCF | 15.90 |
Interest Coverage | 4.08 |
Financial Efficiency
Return on equity (ROE) is 9.73% and return on invested capital (ROIC) is 4.60%.
Return on Equity (ROE) | 9.73% |
Return on Assets (ROA) | 2.87% |
Return on Capital (ROIC) | 4.60% |
Revenue Per Employee | 1.91M |
Profits Per Employee | 37,921 |
Employee Count | 300,000 |
Asset Turnover | 1.44 |
Inventory Turnover | 18.58 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.99% in the last 52 weeks. The beta is 0.53, so CVS Health's price volatility has been lower than the market average.
Beta (5Y) | 0.53 |
52-Week Price Change | -12.99% |
50-Day Moving Average | 14.89 |
200-Day Moving Average | 16.43 |
Relative Strength Index (RSI) | 36.41 |
Average Volume (20 Days) | 17,609 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.94 |
Income Statement
In the last 12 months, CVS Health had revenue of CAD 495.25 billion and earned 9.84 billion in profits. Earnings per share was 7.71.
Revenue | 495.25B |
Gross Profit | 71.18B |
Operating Income | 15.81B |
Pretax Income | 13.20B |
Net Income | 9.84B |
EBITDA | 22.04B |
EBIT | 15.81B |
Earnings Per Share (EPS) | 7.71 |
Balance Sheet
The company has 22.26 billion in cash and 114.72 billion in debt, giving a net cash position of -92.47 billion.
Cash & Cash Equivalents | 22.26B |
Total Debt | 114.72B |
Net Cash | -92.47B |
Net Cash Per Share | n/a |
Equity (Book Value) | 102.80B |
Book Value Per Share | 81.65 |
Working Capital | -15.65B |
Cash Flow
In the last 12 months, operating cash flow was 11.05 billion and capital expenditures -3.83 billion, giving a free cash flow of 7.22 billion.
Operating Cash Flow | 11.05B |
Capital Expenditures | -3.83B |
Free Cash Flow | 7.22B |
FCF Per Share | n/a |
Margins
Gross margin is 14.37%, with operating and profit margins of 3.19% and 1.99%.
Gross Margin | 14.37% |
Operating Margin | 3.19% |
Pretax Margin | 2.66% |
Profit Margin | 1.99% |
EBITDA Margin | 4.45% |
EBIT Margin | 3.19% |
FCF Margin | 1.46% |
Dividends & Yields
CVS Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 45.29% |
Buyback Yield | 2.15% |
Shareholder Yield | 2.15% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CVS Health has an Altman Z-Score of 2.18. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.18 |
Piotroski F-Score | n/a |